Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammation.

Ringelhan, Marc; Reisinger, Florian; Yuan, Detian; Weber, Achim; Heikenwälder, Mathias

doi:10.1002/0471141755.ph1431s67

Institut für Virologie

Back
Back to start of result list
Permanent link for displayed object

Title:: Modeling human liver cancer heterogeneity: virally induced transgenic models and mouse genetic models of chronic liver inflammation.
Document type:: Journal Article
Author(s):: Ringelhan, Marc; Reisinger, Florian; Yuan, Detian; Weber, Achim; Heikenwälder, Mathias
Abstract:: In addition to being the most common primary liver cancer, hepatocellular carcinoma (HCC) is the second most common cause of cancer-related death in humans. Treatment options are limited for this chemoresistant cancer, with liver transplantation and surgical intervention in early stages being the most successful treatments. Drug development over the past 15 years has focused on generating mouse models that mimic the human pathology for HCC. This has enabled the laboratory testing of potentially new human therapeutics. Described in this unit are the classification of HCC and an overview of hepatitis virus-related transgenic and genetically engineered mouse models (GEMMs) that are employed for elucidating the mechanism(s) responsible for the development of HCC, with particular emphasis on genetic, dietary, and environmental factors. © 2014 by John Wiley & Sons, Inc.
Journal title abbreviation:: Curr Protoc Pharmacol
Year:: 2014
Journal volume:: 67
Pages contribution:: 14.31.1-14.31.17
Language:: eng
Fulltext / DOI:: doi:10.1002/0471141755.ph1431s67
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/25446288
Print-ISSN:: 1934-8282
TUM Institution:: II. Medizinische Klinik und Poliklinik (Gastroenterologie); Institut für Virologie
BibTeX